Device‐Based Physical Activity and Low‐Grade Inflammation in People With Multimorbidity: Cross‐Sectional Baseline Analysis From the MOBILIZE Trial
European Journal of Sport Science · 2025
DOI: 10.1002/ejsc.70005 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Sport Science, 2025. Verfasst von Alessio Bricca und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Muscle and Joint Health, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark. Hauptthemen laut MEDLINE: Exercise, Inflammation, Multimorbidity. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council.
Abstract (Originalsprache)
Physical activity (PA) has anti‐inflammatory effects, but its impact on individuals with multimorbidity (two or more chronic conditions) is unclear. We examined the association between device‐measured (i.e., accelerometers) PA and inflammatory biomarkers in people with multimorbidity. In a, preplanned, cross‐sectional analysis from the MOBILIZE trial, 214 participants with multimorbidity provided data on PA and inflammatory biomarkers including interleukin‐1 receptor antagonist (IL‐1ra), high‐sensitivity C‐reactive protein (hs‐CRP), tumor necrosis factor (TNF), and interleukin‐6 (IL‐6). The primary outcome was minutes per day of moderate‐to‐vigorous physical activity (MVPA). Adjusted robust regression models were used to evaluate associations, and BMI was explored as a mediator. Higher MVPA was associated with lower IL‐1ra levels, with a 2% reduction in IL‐1ra for each additional minute of MVPA per day. Participants with at least 10 min/day of MVPA had 33%–45% lower IL‐1ra levels compared to those with less than 1 min/day. Similar results were observed for secondary outcomes. BMI did not mediate the MVPA–IL‐1ra relationship. Even small increases in MVPA appear to be associated with low‐grade inflammation in individuals with multimorbidity. These findings support the promotion of PA in line with WHO guidelines for physical activity even in people with multimorbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Muscle and Joint Health, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark.
- The Research and Implementation Unit PROgrez, Department of Physiotherapy and Occupational Therapy, Næstved-Slagelse-Ringsted Hospitals, Slagelse, Denmark.
- Centre for Physical Activity Research, Rigshospitalet, Copenhagen, Denmark.
- Research Unit for Exercise Epidemiology, Centre of Research in Childhood Health, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark.
- Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
- Department of Cardiology and Endocrinology, Slagelse Hospital, Slagelse, Denmark.
ORCID-Profile: Alessio Bricca
Förderung
- European Research Council
Zitieren
APA
Bricca, A., Legaard, G. E., Mortensen, S. R., Brønd, J. C., Gæde, P., & Skou, S. T. (2025). Device‐Based Physical Activity and Low‐Grade Inflammation in People With Multimorbidity: Cross‐Sectional Baseline Analysis From the MOBILIZE Trial. European Journal of Sport Science. https://doi.org/10.1002/ejsc.70005
Vancouver
Bricca A, Legaard GE, Mortensen SR, Brønd JC, Gæde P, Skou ST. Device‐Based Physical Activity and Low‐Grade Inflammation in People With Multimorbidity: Cross‐Sectional Baseline Analysis From the MOBILIZE Trial. European Journal of Sport Science. 2025. doi:10.1002/ejsc.70005
BibTeX
@article{Bricca2025,
author = {Bricca, Alessio and Legaard, Grit Elster and Mortensen, Sofie Rath and Brønd, Jan Christian and Gæde, Peter and Skou, Søren T},
title = {Device‐Based Physical Activity and Low‐Grade Inflammation in People With Multimorbidity: Cross‐Sectional Baseline Analysis From the MOBILIZE Trial},
journal = {European Journal of Sport Science},
year = {2025},
doi = {10.1002/ejsc.70005}
}
EUVIMED